Trial Design Solutions
-
Integrated Programs To Bridge Molecules From Discovery Into Clinical Development
1/4/2023
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
Experience The Halloran Difference
10/30/2023
By reviewing this established network of repeat customers and best-in-class partners, unearth how companies have been able to maintain effective interactions with regulatory agencies.
-
Strategic Advising For Lifecycle Development: Navigating Complexity With Precision
5/15/2024
Discover tailored strategies crafted to align with your company's goals and objectives that draw upon extensive past, present, and ongoing experiences to drive success at each pivotal stage of your journey.
-
Comprehensive Solutions For Placebo Response Mitigation
8/30/2023
Discover more about this specialized training program focused on mitigating the placebo response, aimed at diminishing its influence.
-
Comprehensive Services For Ophthalmology Drug Development
1/26/2023
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Generate High- Quality Evidence For Pediatric Trials
9/1/2025
Generate the high-quality data required to advance safe and effective therapies for children with solutions that address the unique challenges of pediatric trials.
-
Translational And Biomarker Sciences: Enabling Breakthroughs
5/2/2025
Learn about expert services specializing in precision medicine and biomarker-driven contract and clinical research that can assist you through translational solutions.
-
IRB Services For Institutional Sites
3/2/2023
Advarra can serve as your partner for everything from single investigational sites to multisite research consortia and therapeutic networks.
-
Informed Diversity Action Planning Made Simple
11/26/2024
Develop effective, data-driven Diversity Action Plans tailored to your specific clinical needs with the help of an expert consulting and analytics team.
-
IRB Review Services For Phase I Research
12/22/2021
With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.